Entourage Health Corp.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- George Scorsis
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 276 Queen Street West Toronto ON Canada M5V 2A1
- IPO Date
- Jul 5, 2017
- Website
- entouragehealthcorp.com
- Similar Companies
- Business
- Entourage Health Corp. produces and distributes a diverse portfolio of cannabis products for medical, adult-use, and bulk sales markets in Canada. Its core product range includes dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells these products under various brand names such as Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary’s Medicinals, and Royal City Cannabis. It operates an indoor cultivation and processing facility in Aylmer, Ontario, focusing on product development and fulfillment for both adult-use and medical cannabis markets. Founded in 2014 and headquartered in Aylmer, Ontario, Entourage Health Corp. has recently undergone significant corporate changes including a going-private transaction completed in early 2025, where 1001007762 Ontario Inc., affiliated with the LiUNA Pension Fund of Central and Eastern Canada, acquired all outstanding common shares of the company. This transaction aims to provide immediate shareholder value and position the company for future growth and operational flexibility. In 2025, Entourage expanded its Starseed Medicinal telehealth platform to include new non-cannabis prescription offerings, adding four categories of prescription medications beyond its industry-leading medical cannabis program. This strategic enhancement reinforces its commitment to comprehensive, patient-centered wellness solutions delivered through partnerships with healthcare providers, unions, insurance firms, and clinic partners across Canada. The company operates primarily in Canada’s cannabis industry, targeting both medical patients and adult-use consumers through its broad product assortment and multiple established brands. The recent corporate restructuring and expansion into telehealth and prescription services mark a strategic shift to diversify and enhance its health and wellness offerings. Entourage Health Corp. was formerly known as WeedMD Inc. before its rebranding in July 2021 and continues to leverage its strong market position with a focus on innovation and comprehensive patient care solutions within the Canadian cannabis sector.
Entourage Health Corp. Announces Closing of Plan of Arrangement
Entourage Health Increases Senior Secured Credit Facility
Entourage Health Corp. Announces Shareholder Approval of Going-Private Transaction
Entourage Health Corp. Enters into Arrangement Agreement for Going-Private Transaction
Entourage Health Corp. (ETRGF) Q3 2024 Earnings Call Transcript
Entourage Health Reports Strong Third Quarter 2024 Financial Results
Entourage Health to Host Third Quarter 2024 Earnings Conference Call
Entourage Health Provides Company Update
Entourage Health Increases Senior Secured Credit Facility
Entourage Health Provides Company Update
Entourage Health Corp. (ETRGF) Q2 2024 Earnings Call Transcript
Entourage Health to Host Second Quarter 2024 Financial Results Call
Entourage Announces Results of 2024 Annual General Meeting of Shareholders
Entourage Health Corp. (ETRGF) Q1 2024 Earnings Call Transcript
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter
Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag®
Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues
Entourage Health to Report Fiscal Year 2023 Financial Results
Entourage Health Provides Corporate Update
Entourage Health Corp (ETRGF) Q3 2023 Earnings Call Transcript